Skip to main content

Advertisement

SpringerLink
Log in

Multicentric study of efficacy and safety of growth hormone use in growth hormone deficient children in India

  • Original Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Growth Hormone being very expensive in India data on use of recombinant human growth hormone (rhGH) is scarce. The authors studied the effect and safety of one year of therapy with rhGH on growth velocity and predicted final height in Indian patients with growth hormone deficiency (GHD). A multicentric, prospective, open trial with rhGH was performed on 15 patients. Patients received rhGH in a dose of 0.7 IU (0.23 mg)/Kg/week. The mean pretreatment height was 111.2cms {SD 12.4}, height velocity was 3.1 cms per year {1.2} and predicted height was 146.5 cms {10.4} at a mean age of 12.0 (2.8). At the end of therapy mean height was 123.4 {11.9}, height velocity was 12.1 cms per year {2.8} and the predicted height was 153.0 cm {9.4}. The increase in predicted height was thus 6.5cm (4.2). The increment in height velocity with growth hormone therapy was statistically significant (p value= 0.001). The present study shows that children with growth hormone deficiency in India also benefit from therapy with rhGH even when treatment is started late as compared to the published Western data and there is a potential for increased final height.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Flodh H. Update on clinical use and experience of somatonorm (somatrem). Acta Pediatr Scand 1987; 337: 130–133.

    CAS  Google Scholar 

  2. Menon PSN, Virmani A, Sethi AK. Biosynthetic Growth hormone Therapy in children with Growth Hormone efficiency: Experience at AIIMS, New Delhi. Indian J Pediatr 1991; 58: 71–77.

    PubMed  Google Scholar 

  3. Raghupathy P. Growth Hormone Deficiency: A Vellore Experience: 1986–1990. Indian J Pediatr 1991; 58: 79–79.

    PubMed  Google Scholar 

  4. Tanner JM, Healy MJ, Goldstein H, Cameron N. Assessment of skeletal maturity and prediction of adult height (TW3 method). 3rd ed. London; WB Saunders; 2001.

    Google Scholar 

  5. Agarwal DK, Agarwal KN, Upadhyay SK, Mittal R, Prakash R, Rai S. Physical and sexual growth pattern of affluent Indian children from 5–18 years of age. Indian Pediatrics 1992; 29: 1203–1282.

    PubMed  CAS  Google Scholar 

  6. Dehiya RD, Bhartiya D, Kapadia C, Desai MP. Insulin Like Growth Factor-1, Insulin Like Growth Factor Binding Protein-3 and Acid Labile Subunit Levels in Healthy Children and Adolescents in Mumbai Suburbs. Indian Pediatrics 2000; 37: 990–997.

    PubMed  CAS  Google Scholar 

  7. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity and weight velocity: British children 1965. Arch Dis Child 1966; 41: 454–471.

    PubMed  CAS  Google Scholar 

  8. Frasier SD. Human pituitary growth hormone (hGH) therapy in growth hormone deficiency. Endocrine Reviws 1983; 4: 155–156.

    CAS  Google Scholar 

  9. Bundak R, Hindmarsh PC, Smith PJ, Brook CG. Long-term auxological effects of human growth hormone. J Pediatr 1988; 112: 875–879.

    Article  PubMed  CAS  Google Scholar 

  10. Ranke MB, Bierich JR. Long term treatment of hypopituitarism. In Ranke MB, Bierich JR, eds. Growth Hormone Deficiency. Baltimore; Urban and Schwarzenber; 1983.

    Google Scholar 

  11. Cowell CT, Dietsch S, Greenacre P. Growth Hormone therapy for 3 years: The OZGROW experience. J Peditr Child Health 1996; 32: 86–93.

    CAS  Google Scholar 

  12. Darendeliler F, Hindmarsh PC, Brook CG. Dose-response curves for treatment with biosynthetic human growth hormone. J Endocrinology 1990; 125: 311–316.

    Article  CAS  Google Scholar 

  13. Frasier D, Costin G, Lippe BM, Aceto T, Bunger PF. Dose response curve for human growth hormone. J Clin Endocrinology & Metabolism 1981; 53: 1213–1217.

    Article  CAS  Google Scholar 

  14. Hindmarsh PC, Brook CGD. Normal Growth and its Endocrine control. In Clinical Pediatric Endocrinology, 3rd edn. Ed. Brook CGD. London, Blackwell Science, 1995; 185–106.

    Google Scholar 

  15. Bavdekar A, Yajnik CS, Fall CH, Bapat S, Pandit AN, Deshpande V, Bhave S, Kellingray SD, Joglekar C. Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes 1999; 48(12): 2422–2429.

    Article  PubMed  CAS  Google Scholar 

  16. Desai MP, Colaco MP. Growth Hormone Deficiency and Insensitivity. In: Desai MP, Bhatia V, Menon PS, eds. Pediatric Endocrine Disorders. 1st ed. Hyderabadh; Orient Longman; 2001; 87–105.

    Google Scholar 

  17. Reserve Bank Of India. Handbook of Statistics on Indian Economy. Reserve Bank of India 2004.

Download references

Author information

Authors and Affiliations

  1. Medical Services and Product Development, LG Life Sciences India Pvt. Ltd., Hirabai Cowasji Jehangir Medical Research Institute, Jehangir Hospital, Pune, India

    M. Nandy

  2. Consultant Paediatric Endocrinologist, Hirabai Cowasji Jehangir Medical Research Institute, Jehangir Hospital, 32, Sassoon Road, Pune, 411001, India

    V. V. Khadilkar

Authors
  1. V. V. Khadilkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. V. Khadilkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Nandy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. B. Maskati
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. V. Khadilkar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khadilkar, V.V., Khadilkar, A.V., Nandy, M. et al. Multicentric study of efficacy and safety of growth hormone use in growth hormone deficient children in India. Indian J Pediatr 74, 51–54 (2007). https://doi.org/10.1007/s12098-007-0027-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-007-0027-9

Key words

Search

Navigation